Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.65
+0.01000.02%
Post-market: 41.650.00000.00%19:59 EDT
Volume:230.10K
Turnover:9.56M
Market Cap:301.96M
PE:- -
High:42.04
Open:41.84
Low:41.25
Close:41.64
52wk High:42.97
52wk Low:23.90
Shares:7.25M
Float Shares:7.25M
Volume Ratio:0.80
T/O Rate:3.17%
Dividend:0.28
Dividend Rate:0.67%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

Reuters
·
Oct 02

AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials

TIPRANKS
·
Oct 02

Why Did Moderna Stock Gain (MRNA) in After-Hours Trading on Thursday?

TIPRANKS
·
Oct 02

PRECISE and AWS to build systems for Singapore's 450,000-person genomics study

Nurdianah Md Nur
·
Oct 02

Moderna to Join Nasdaq 100, Replacing Warner Bros Discovery

Reuters
·
Oct 02

Rpt-NASDAQ - Moderna to Join NASDAQ-100 Index Replacing Warner Bros. Discovery on October 9, 2026

THOMSON REUTERS
·
Oct 02

Vortex Energy Expands Saskatchewan Portfolio with Meadows Project Acquisition

TIPRANKS
·
Oct 02

Revolution Medicines Chief Development Officer Alan B. Sandler Disposes of USD 1,264,082 in Common Shares

Reuters
·
Oct 02

Vertex adds AI-focused independent director to board

TIPRANKS
·
Oct 02

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

GlobeNewswire
·
Oct 02

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Oct 02

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.21% on Oct 1: What Investors Need To Know

TradingKey
·
Oct 02

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-01

Reuters
·
Oct 02

Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing

TIPRANKS
·
Oct 01

Twist Bioscience is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 01

Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test

Simply Wall St.
·
Oct 01

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

GlobeNewswire
·
Oct 01

Veeva supporting transformation of medicine through AI, Barron’s reports

TIPRANKS
·
Oct 01

Twist Bioscience price target raised to $212 from $107 at Guggenheim

TIPRANKS
·
Oct 01

Vertex appoints Saha to Board of Directors

TIPRANKS
·
Oct 01